Etoposide (VP-16-213) and cis-dichlorodiammineplatinum (DDP) in advanced breast carcinoma resistant to previous chemotherapy
Athanassiades, P.; Bacoyiannes, H.; Kontoyiannes, D.
Chemioterapia International Journal of the Mediterranean Society of ChemoTherapy 5(2): 125-127
1986
ISSN/ISBN: 0392-906X PMID: 3518965 Document Number: 284120
The combination of etoposide (VP-16-213) and cis-dichlorodiammineplatinum (DDP) was evaluated in 23 patients with advanced metastatic breast carcinoma who had not responded to or who had relapsed after previous two-arm chemotherapy (CMF and AV). Nineteen patients were evaluable for efficacy and one of them attained objective response. Stability of the disease was observed in 6 patients.
Document emailed within 1 workday
Related Documents
Yuki, K.; Kodama, Y.; Emoto, K.; Yukawa, O.; Onda, J.; Uozumi, T. 1989: A case report of advanced malignant mixed germ cell tumor of parasellar origin indicating marked efficacy of a salvage combined chemotherapy of CDDP and etoposide and subsequent chemotherapy using oral etoposide Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(8 Pt 1): 2651-2654Ohwada, S.; Miyamoto, Y.; Takeshita, M.; Fujii, T.; Uchida, O.; Tanahasi, Y.; Aoyagi, H.; Izuo, M. 1989: Advanced and recurrent gastric carcinoma: combination chemotherapy with etoposide (E), adriamycin (A), cisplatin (P) = EAP Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(10): 3487-3489
Kato, M.; Kinoshita, K.; Sawa, T.; Yoshimitsu, S.; Tomita, F.; Takano, Y.; Segawa, M.; Ohyama, S.; Yonemura, Y.; Miwa, K. 1990: Neoadjuvant chemotherapy of far advanced gastric cancer--effect of preoperative chemotherapy by PMUE (CDDP, MMC, UFT, etoposide Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(3 Part 1): 391-396
Yap, H.Y.; Salem, P.; Hortobagyi, G.N.; Bodey, G.P.; Buzdar, A.U.; Tashima, C.K.; Blumenschein, G.R. 1978: Phase Ii study of cis-dichlorodiammineplatinum(II) in advanced breast cancer Cancer Treatment Reports 62(3): 405-408
Vogl, S.E.; Berenzweig, M.; Kaplan, B.H.; Moukhtar, M.; Bulkin, W. 1979: The CHAD and HAD regimens in advanced ovarian cancer: combination chemotherapy including cyclophosphamide, hexamethylmelamine, adriamycin, and cis-dichlorodiammineplatinum(II) Cancer Treatment Reports 63(2): 311-317
Rodenburg, C.J.; Nooy, M.A.; Briët, E. 1985: Microangiopathic haemolytic anaemia with advanced breast carcinoma: improvement with chemotherapy Netherlands Journal of Medicine 28(4): 169-171
Paone, J.F.; Abeloff, M.D.; Ettinger, D.S.; Arnold, E.A.; Baker, R.R. 1981: The correlation of estrogen and progesterone receptor levels with response to chemotherapy for advanced carcinoma of the breast Surgery Gynecology and Obstetrics 152(1): 70-74
Hayakawa, M.; Morise, K.; Oka, Y.; Saito, H. 1987: Combination chemotherapy of UFT, etoposide and CDDP in advanced gastric cancer Gan no Rinsho. Japan Journal of Cancer Clinics 33(7): 793-798
Doberauer, C.; Ohl, S. 1989: Advanced mycosis fungoides: chemotherapy with etoposide, methotrexate, bleomycin, and prednimustine Acta Dermato-Venereologica 69(6): 538-540
Hashimoto, H.; Tokumitsu, M.; Morikawa, M.; Numata, A.; Yachiku, S.; Iuchi, H.; Yamauchi, K. 1996: Chemotherapy for advanced urothelial cancer patients with a combination of low-dose consecutive cisplatin and etoposide Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(7): 941-944
Ciuleanu, T.E.; Curcă, R.; Iancu, D.; Todor, N.; Cebotaru, C.; Radulescu, I.; Banu, E.; Ghilezan, N. 2002: First-line chemotherapy with topotecan and etoposide in advanced small cell lung cancer. a phase Ii study Journal of Buon: Official Journal of the Balkan Union of Oncology 7(1): 43-46
Crawford, E.D.; Daneshgari, F.; Majeski, S.A. 1992: Etoposide in the treatment of hormone-refractory advanced carcinoma of the prostate Seminars in Oncology 19(6 Suppl 14: 53-57
Ikeda, I.; Shuin, T.; Yao, M.; Kubota, Y.; Hosaka, M. 1993: New salvage chemotherapy (cisplatin, adriamycin, bleomycin, methotrexate, etoposide) for advanced nonseminomatous testicular cancer: experience in three cases Hinyokika Kiyo. Acta Urologica Japonica 39(3): 237-242
Adachi, K.; Ogawa, M.; Inagaki, J.; Horikoshi, N.; Inoue, K.; Ikeda, K.; Usui, N.; Nakata, H.; Tada, A.; Aiba, K. 1984: A combination chemotherapy consisting of vincristine, etoposide and cyclophosphamide (VEC) for small cell carcinoma of the lung Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(8): 1617-1622
Nishioka, Y.; Kitada, O.; Meguro, T.; Aragane, K.; Tanimukai, T.; Nakamura, H.; Nakahama, H.; Matsuyama, T.; Sugita, M.; Yano, T.; Takenaka, Y.; Takamitsu, Y. 1999: Nedaplatin and etoposide combination chemotherapy in a patient with small cell carcinoma undergoing hemodialysis Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(4): 527-530
Menczer, J.; Ben-Baruch, G.; Rizel, S.; Brenner, H. 1995: Intraperitoneal chemotherapy with cisplatin and etoposide in ovarian carcinoma patients who are clinically in complete remission European Journal of Gynaecological Oncology 16(1): 12-17
Ardizzoni, A.; Canobbio, L.; Pronzato, P.; Rubagotti, A.; De Palma, M.; Baracco, F.; Serrano, J.; Serrano, S.; Faravelli, B.; Nosenzo, M. 1986: Etoposide and high-dose cisplatin in good-risk patients with advanced squamous cell carcinoma and adenocarcinoma of the lung Cancer Treatment Reports 70(7): 891-892
Chen, G.; Teicher, B.A.; Frei, E. 1996: Differential interactions of Pgp inhibitor thaliblastine with adriamycin, etoposide, taxol and anthrapyrazole CI941 in sensitive and multidrug-resistant human MCF-7 breast cancer cells Anticancer Research 16(6b): 3499-3505
Nishikawa, A.; Hashimoto, H.; Takeda, M.; Kontani, K.; Miyatake, T.; Mimura, M.; Nagamatsu, M.; Yokoi, T. 2016: Retrospective analysis of the survival benefit of chemotherapy for recurrent or advanced epithelial ovarian carcinoma in patients previously treated with paclitaxel plus platinum-based chemotherapy European Journal of Gynaecological Oncology 37(4): 451-454
Futagami, F.; Asano, K.; Matsumura, A.; Ohhori, I.; Sasaki, M.; Kawahara, E. 1999: A case of small cell carcinoma of the stomach with multiple liver and lung metastases successfully treated by combined chemotherapy with cisplatin and etoposide Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(1): 149-152